Publication: Statistical Validation of Synthetic Data for Lung Cancer Patients Generated by Using Generative Adversarial Networks
dc.contributor.author | Gonzalez-Abril, Luis | |
dc.contributor.author | Angulo, Cecilio | |
dc.contributor.author | Antonio Ortega, Juan | |
dc.contributor.author | Lopez-Guerra, Jose-Luis | |
dc.contributor.authoraffiliation | [Gonzalez-Abril, Luis] Univ Seville, Appl Econ & Dept, Seville 41018, Spain | |
dc.contributor.authoraffiliation | [Angulo, Cecilio] Univ Politecn Cataluna, Intelligent Data Sci & Artificial Intelligence Re, Barcelona 08034, Spain | |
dc.contributor.authoraffiliation | [Angulo, Cecilio] Inst Robot & Informat Ind CSIC UPC, Barcelona 08028, Spain | |
dc.contributor.authoraffiliation | [Antonio Ortega, Juan] Univ Seville, Comp Sci Dept, Seville 41012, Spain | |
dc.contributor.authoraffiliation | [Lopez-Guerra, Jose-Luis] Univ Hosp Virgen del Rocio, Dept Radiat Oncol, Seville 41013, Spain | |
dc.contributor.funder | Spanish Ministry of Science, Innovation and Universities (AEI/FEDER, UE) | |
dc.date.accessioned | 2023-05-03T13:53:32Z | |
dc.date.available | 2023-05-03T13:53:32Z | |
dc.date.issued | 2022-10-01 | |
dc.description.abstract | The development of healthcare patient digital twins in combination with machine learning technologies helps doctors in therapeutic prescription and in minimally invasive intervention procedures. The confidentiality of medical records or limited data availability in many health domains are drawbacks that can be overcome with the generation of synthetic data conformed to real data. The use of generative adversarial networks (GAN) for the generation of synthetic data of lung cancer patients has been previously introduced as a tool to solve this problem in the form of anonymized synthetic patients. However, generated synthetic data are mainly validated from the machine learning domain (loss functions) or expert domain (oncologists). In this paper, we propose statistical decision making as a validation tool: Is the model good enough to be used? Does the model pass rigorous hypothesis testing criteria? We show for the case at hand how loss functions and hypothesis validation are not always well aligned. | |
dc.identifier.doi | 10.3390/electronics11203277 | |
dc.identifier.essn | 2079-9292 | |
dc.identifier.unpaywallURL | https://www.mdpi.com/2079-9292/11/20/3277/pdf?version=1665562658 | |
dc.identifier.uri | http://hdl.handle.net/10668/20972 | |
dc.identifier.wosID | 872609300001 | |
dc.issue.number | 20 | |
dc.journal.title | Electronics | |
dc.journal.titleabbreviation | Electronics | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.publisher | Mdpi | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | personalized medicine | |
dc.subject | generative adversarial network | |
dc.subject | lung cancer | |
dc.subject | validation tools | |
dc.title | Statistical Validation of Synthetic Data for Lung Cancer Patients Generated by Using Generative Adversarial Networks | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 11 | |
dc.wostype | Article | |
dspace.entity.type | Publication |